Skip to main content
. 2017 Feb 2;11(7):885–893. doi: 10.1093/ecco-jcc/jjx003

Figure 2.

Figure 2.

Overview of cytokines signalling via the JAK-STAT pathway. JAK inhibitors interfere with a number of key pro-inflammatory cytokines involved in the pathogenesis of inflammatory bowel disease [IBD]. IFN, interferon; IL, interleukin; GM-CSF, granulocyte macrophage colony-stimulating factor; OSM oncostatin M; GH growth hormone; EPO erythropoietin; TPO thrombopoietin. Adapted with permission from Rawlings et al., J Cell Sci 2004;117:1281–3.